Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With: Abortion

  • New Research on Advance Provision Reveals Interest and Use in United States Since 2022

    Interest in advance provision of abortion medication was high even before the U.S. Supreme Court overturned Roe v. Wade, according to recent research. Many of those interested in advance provision were more likely to be highly motivated to prevent pregnancy. They had been using highly effective contraceptives, were well-educated, had private insurance, and were not poor.

  • As Uncertainty Looms, More People Request Advance Provision of Mifepristone

    Interest in advance provision of abortion medications mifepristone and misoprostol has increased dramatically in the post-Roe era. It remains popular as a U.S. Supreme Court case looms over whether mifepristone should remain available. Advance provision is one tool to help expand access to the medication.

  • Policy Changes Helped Increase LARC Use

    National health statistics and new research point to increased interest in and use of long-acting reversible contraception (LARC). One in four women reported using LARC, according to the 2015-2019 National Survey of Family Growth.

  • Fetal Personhood Laws Give Zygotes the Same Rights as Pregnant Women

    Laws based on the concept of fetal personhood are creating a catch-22 for women who experience pregnancy crises or whom health system staff suspect of having engaged in wrongdoing.

  • Lawsuits Filed to Restore Women’s Reproductive Rights

    South Carolina, Texas, and other states have consistently targeted Planned Parenthood clinics with lawsuits that fail and then are appealed repeatedly.

  • A Partial List of 2023 Lawsuits on Abortion and Reproductive Rights

    Reproductive rights attorneys were busy in 2023 and are continuing the legal fight in 2024.

  • Ever-Changing Legal Landscape Leaves Providers, Women, and Lawyers on Edge

    Reproductive health lawyers nationwide are trying to help women maintain access to abortion and contraception, but the appeals and lawsuits are unending. Lawyers committed to reproductive health causes have filed lawsuits to maintain people’s access to contraception, reproductive healthcare, and abortion care.

  • EMTALA Still Poses Challenges After All These Years

    EMTALA has encouraged the safe care of emergent patients since 1986, yet it still poses significant compliance challenges and hospitals are cited for violations. Understanding the potential pitfalls and best practices can help healthcare organizations avoid serious consequences.

  • Rh Sensitization Following Induced Abortion

    In this multicenter, observational, prospective cohort study, flow cytometry was used to detect circulating fetal red blood cells (fRBCs) in maternal blood among 506 participants before and after induced abortion up to 12 weeks’ gestation. Only three participants had elevated fRBCs at baseline, and only one of these had elevated fRBC counts following the abortion, which indicates that first trimester abortion is not a risk factor for Rh sensitization.

  • The Studied and Unstudied Dangers of ‘Abortion Reversal’

    Colorado’s Senate Bill 190, signed in May 2023, declared the practice of “abortion reversal” to be unprofessional conduct, meaning that healthcare providers providing this treatment could face sanctions to their licensure. However, Colorado’s Medical Board subsequently issued a draft rule declaring “abortion reversal” as “generally accepted standard of practice” and, therefore, potentially acceptable. Clearly, confusion exists among state medical boards and legislatures, and, potentially, among healthcare providers. This commentary will review both the medical evidence regarding “abortion reversal” and the legal context so that providers can be better informed and communicate the best evidence to their patients.